Epidarex Portfolio News

15 Oct

57

Harpoon Medical Reports Results Of Ten Patient Early Feasibility Trial Of Its Repair System For Off-Pump, Minimally Invasive Treatment Of Mitral Valve Regurgitation (“MR”)

In All, Portfolio

Outstanding clinical results reported at 2015 Transcatheter Therapeutics Conference in San Francisco. Baltimore, MD, Oct. 15, 2015 – Harpoon Medical, Inc. a medical device company focused on minimally invasive mitral valve repair, announced that it has presented clinical results of ten patients enrolled in an…

24 Sep

46

Harpoon Medical’s Mitral Valve Repair Device To Minimize Invasiveness, Reduce Time of Surgery and Recovery

In All, Portfolio

By Zach Kaufman, Medgadget The device, produced by Baltimore-based Harpoon Medical, seeks to provide another in a series of recent improvements in mitral valve repair technology. While perhaps less revolutionary in form than Valtech Cardio’s Cardioband that received its CE Mark approval last week, the Harpoon…

17 Sep

42

EM Imaging Obtains Global Licence For Optical Agent That Detects Cancer Early

In All, Portfolio

Edinburgh, United Kingdom, 16th September, 2015 – Edinburgh Molecular Imaging Ltd. (EM Imaging) has signed an exclusive global license for a novel optical imaging agent that could improve the detection of early-stage colorectal (bowel) cancer. EM Imaging, a company which develops and commercialises novel optical imaging agents,…

15 Sep

23

Harpoon Medical Enrolls Ten Patients in Early Feasibility Study with 100% Procedural Success

In All, Portfolio

The company has also received $1.4M of a $2M bridge round to accelerate its clinical program Baltimore, MD, Sept. 15, 2015 – Harpoon Medical, a medical device company focused on minimally-invasive, beating-heart, mitral valve repair, announced today that ten patients with severe degenerative mitral valve…

02 Sep

28

Edinburgh Molecular Imaging Ltd Appoints New Chairman

In All, Portfolio

Edinburgh, United Kingdom, 2nd September 2015 – The Board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans CBE CEng as non-executive Chairman with effect from 31st August 2015. In an industrial career spanning 35 years John held…

16 Jul

31

Apellis Pharmaceuticals Announces Formation of Scientific Advisory Board

In All, Portfolio

Crestwood, KY – July 15, 2015 – Apellis Pharmaceuticals, Inc., a clinical stage complement immunotherapy company, announced today the formation of a Scientific Advisory Board (SAB) comprised of physicians and scientists recognized as key opinion leaders in the areas of immunology, pulmonology, ophthalmology and hematology….

20 May

37

New Drug Discovery Company Announces Additional Funding to Tackle Chronic Respiratory Disease

In All, Portfolio

Brighton, Sussex, May 20th 2015 – Enterprise Therapeutics Ltd, a drug discovery company focused on new therapeutics for respiratory diseases, today announced that it has secured an additional £2.4m ($3.6m) in Series-A financing. The funds are comprised of £2m by new investor, Imperial Innovations and…

07 May

37

Harpoon Medical Enrolls Initial Three Patients In Early Feasibility Study Of Its Repair System For Off-Pump, Minimally Invasive Treatment Of Mitral Valve Regurgitation

In All, Portfolio

Baltimore, MD, May 7, 2015 – Harpoon Medical, a medical device company focused on minimally invasive mitral valve repair, announced today that it has enrolled the initial three patients in an Early Feasibility Study of its repair system for the minimally invasive, beating-heart treatment of MR….